<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02076776</url>
  </required_header>
  <id_info>
    <org_study_id>R03HD073566</org_study_id>
    <nct_id>NCT02076776</nct_id>
  </id_info>
  <brief_title>Heart-Brain Retraining for Stroke Rehabilitation</brief_title>
  <official_title>Heart-Brain Retraining: Forced Aerobic Exercise for Stroke Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to gain a better understanding of how different types of
      exercise can help people after a stroke. The investigators want to study if different types
      of exercise will improve the use of arm and hand function after a stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is the leading cause of disability in the United States with approximately 795,000 new
      or recurrent strokes per year. An estimated two thirds of patients post-stroke cannot
      incorporate the affected upper extremity (UE) into their activities of daily living. In
      addition, stroke survivors experience a 60% decrease in cardiovascular capacity, which
      contributed to disability and diminished quality of life. Developing rehabilitation
      techniques to optimize motor recovery while improving cardiovascular endurance would benefit
      the stroke population.

      Animal studies using a forced exercise (FE) paradigm, in which the rodent is exercised on a
      motorized treadmill at a rate greater than its voluntary rate, indicate an endogenous
      increase in neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and
      glial-derived neurotrophic factor (GDNF). These neurotrophic factors are thought to underlie
      neuroplasticity and motor learning. It is hypothesized that patients with stroke, due to
      decreased motor cortical output, cannot sustain high rates of voluntary exercise necessary to
      trigger the endogenous release of neurotrophic factors; therefore, forced-exercise is
      necessary to augment their voluntary efforts and will be superior to voluntary exercise in
      facilitating motor recovery. When coupled with repetitive task practice (RTP) of the UE, an
      effective form of UE rehabilitation, FE will prime the brain for neuroplasticity. We have
      developed a safe and effective method of delivering forced-exercise to Parkinson's disease
      (PD) patients (NIH R21HD056316). Clinical and imaging data with PD patients indicate
      forced-exercise, but not voluntary exercise, triggers a neurophysiologic response in the
      central nervous system resulting in global improvements in motor and non-motor functioning
      and increased cortical and subcortical activation. The aim of this project is to conduct a
      preliminary trial to compare the effects of forced to voluntary exercise when coupled with
      RTP in promoting the recovery of motor function in patients with stroke.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wolf Motor Function Test (WMFT)</measure>
    <time_frame>Baseline, End of Treatment (8 weeks); End of Treatment + 4 week (12 weeks)</time_frame>
    <description>This consists of 2 strength tasks and 15 timed tasks of both the affected UE and the unaffected UE. Total Functional Ability Score is reported, scores range from 0-75, with higher scores indicating a better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Fugl-Meyer Assessment (FMA)</measure>
    <time_frame>Baseline, End of Treatment (8 weeks); End of Treatment + 4 week (12 weeks)</time_frame>
    <description>This is a 33 item assessment of post-stroke UE impairment. Total score is reported, scores range from 0-66, with higher scores indicating a better outcome.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The Stroke Impact Scale (SIS)</measure>
    <time_frame>Baseline, End of Treatment (8 weeks); End of Treatment + 4 week (12 weeks)</time_frame>
    <description>This is a self-reported questionnaire evaluating quality of life. Normalized Hand Function is reported, scores range from 0-100, with higher scores indicating a better outcome.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Repetitive Task Practice (RTP)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group focuses on RTP.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Voluntary cycling + RTP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group involves one biking session and one RTP session three times per week for eight weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Assisted cycling + RTP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group involves one biking session and one RTP session three times per week for eight weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Repetitive Task Practice (RTP)</intervention_name>
    <description>This group will preform arm and hand therapy.</description>
    <arm_group_label>Repetitive Task Practice (RTP)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voluntary cycling + RTP</intervention_name>
    <description>This group will preform arm and hand therapy and cycle on a bike.</description>
    <arm_group_label>Voluntary cycling + RTP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Assisted cycling + RTP</intervention_name>
    <description>This group will preform arm and hand therapy and cycle on a bike.</description>
    <arm_group_label>Assisted cycling + RTP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to provide informed consent

          -  Within 6-12 months of diagnosis of single ischemic or hemorrhagic stroke, confirmed
             with neuroimaging

          -  Fugl-Meyer Motor Score 19-55 in involved upper extremity

          -  Approval from patient's primary care physician

          -  Age between 18 and 85 years

        Exclusion Criteria:

          -  Hospitalization for myocardial infarction, congestive heart failure, or heart surgery
             (CABG or valve replacement) within 3 months of study enrollment

          -  Serious cardiac arrhythmia

          -  Hypertrophic cardiomyopathy

          -  Severe aortic stenosis

          -  Cardiac pacemaker

          -  Pulmonary embolus

          -  Other medical or musculoskeletal contraindication to exercise

          -  Significant cognitive impairment (unable to follow 1-2 step commands) or major
             psychiatric disorder (major depression, generalized anxiety) that will cause
             difficulty in study participation

          -  Anti-spasticity injection (botox) in upper extremity within 3 months of study
             enrollment

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jay Alberts, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>February 24, 2014</study_first_submitted>
  <study_first_submitted_qc>February 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2014</study_first_posted>
  <results_first_submitted>July 2, 2018</results_first_submitted>
  <results_first_submitted_qc>July 2, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 1, 2018</results_first_posted>
  <last_update_submitted>August 2, 2018</last_update_submitted>
  <last_update_submitted_qc>August 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Jay Alberts</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Exercise</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Neuroplasticity</keyword>
  <keyword>Task Practice</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>One participant consented to the study, but had abnormal stress test results. This participant declined follow-up care and withdrew from the study before completing the baseline and randomization process.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Repetitive Task Practice (RTP)</title>
          <description>This group focuses on RTP.
Repetitive Task Practice (RTP): This group will preform arm and hand therapy.</description>
        </group>
        <group group_id="P2">
          <title>Voluntary Cycling + RTP</title>
          <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Voluntary cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
        </group>
        <group group_id="P3">
          <title>Assisted Cycling + RTP</title>
          <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Assisted cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Repetitive Task Practice (RTP)</title>
          <description>This group focuses on RTP.
Repetitive Task Practice (RTP): This group will preform arm and hand therapy.</description>
        </group>
        <group group_id="B2">
          <title>Voluntary Cycling + RTP</title>
          <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Voluntary cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
        </group>
        <group group_id="B3">
          <title>Assisted Cycling + RTP</title>
          <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Assisted cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="6"/>
            <count group_id="B4" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.67" spread="7.45"/>
                    <measurement group_id="B2" value="59.38" spread="15.57"/>
                    <measurement group_id="B3" value="44.83" spread="11.72"/>
                    <measurement group_id="B4" value="55.70" spread="13.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Wolf Motor Function Test</title>
          <description>Upper extremity function test. Total Functional Ability Score is reported. Scores range from 0-75 and higher scores indicate better function.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.17" spread="17.38"/>
                    <measurement group_id="B2" value="49.75" spread="20.25"/>
                    <measurement group_id="B3" value="59.83" spread="9.06"/>
                    <measurement group_id="B4" value="51.40" spread="16.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fugl-Meyer Assessment</title>
          <description>Upper extremity motor test. Total score is reported. Scores range from 0-66 and higher scores indicate less impairment.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.83" spread="7.83"/>
                    <measurement group_id="B2" value="34.75" spread="13.58"/>
                    <measurement group_id="B3" value="36.17" spread="7.41"/>
                    <measurement group_id="B4" value="32.80" spread="10.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stroke Impact Scale</title>
          <description>Quality of life questionnaire. Normalized Hand Function score is reported. Scores range from 0-100, with higher values indicating better self-reported quality of life.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.67" spread="35.73"/>
                    <measurement group_id="B2" value="34.38" spread="28.72"/>
                    <measurement group_id="B3" value="50.83" spread="32.00"/>
                    <measurement group_id="B4" value="38.50" spread="31.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Wolf Motor Function Test (WMFT)</title>
        <description>This consists of 2 strength tasks and 15 timed tasks of both the affected UE and the unaffected UE. Total Functional Ability Score is reported, scores range from 0-75, with higher scores indicating a better outcome.</description>
        <time_frame>Baseline, End of Treatment (8 weeks); End of Treatment + 4 week (12 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Repetitive Task Practice (RTP)</title>
            <description>This group focuses on RTP.
Repetitive Task Practice (RTP): This group will preform arm and hand therapy.</description>
          </group>
          <group group_id="O2">
            <title>Voluntary Cycling + RTP</title>
            <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Voluntary cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
          </group>
          <group group_id="O3">
            <title>Assisted Cycling + RTP</title>
            <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Assisted cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
          </group>
        </group_list>
        <measure>
          <title>Wolf Motor Function Test (WMFT)</title>
          <description>This consists of 2 strength tasks and 15 timed tasks of both the affected UE and the unaffected UE. Total Functional Ability Score is reported, scores range from 0-75, with higher scores indicating a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.17" spread="17.38"/>
                    <measurement group_id="O2" value="49.75" spread="20.25"/>
                    <measurement group_id="O3" value="59.83" spread="9.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EOT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.80" spread="18.94"/>
                    <measurement group_id="O2" value="48.83" spread="18.10"/>
                    <measurement group_id="O3" value="68.67" spread="6.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EOT+4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.80" spread="21.35"/>
                    <measurement group_id="O2" value="50.33" spread="19.35"/>
                    <measurement group_id="O3" value="69.50" spread="5.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Fugl-Meyer Assessment (FMA)</title>
        <description>This is a 33 item assessment of post-stroke UE impairment. Total score is reported, scores range from 0-66, with higher scores indicating a better outcome.</description>
        <time_frame>Baseline, End of Treatment (8 weeks); End of Treatment + 4 week (12 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Repetitive Task Practice (RTP)</title>
            <description>This group focuses on RTP.
Repetitive Task Practice (RTP): This group will preform arm and hand therapy.</description>
          </group>
          <group group_id="O2">
            <title>Voluntary Cycling + RTP</title>
            <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Voluntary cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
          </group>
          <group group_id="O3">
            <title>Assisted Cycling + RTP</title>
            <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Assisted cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
          </group>
        </group_list>
        <measure>
          <title>The Fugl-Meyer Assessment (FMA)</title>
          <description>This is a 33 item assessment of post-stroke UE impairment. Total score is reported, scores range from 0-66, with higher scores indicating a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.83" spread="7.83"/>
                    <measurement group_id="O2" value="34.75" spread="13.58"/>
                    <measurement group_id="O3" value="36.17" spread="7.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EOT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.80" spread="11.97"/>
                    <measurement group_id="O2" value="35.33" spread="14.65"/>
                    <measurement group_id="O3" value="48.50" spread="6.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EOT+4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.40" spread="15.04"/>
                    <measurement group_id="O2" value="37.00" spread="17.56"/>
                    <measurement group_id="O3" value="51.17" spread="3.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Stroke Impact Scale (SIS)</title>
        <description>This is a self-reported questionnaire evaluating quality of life. Normalized Hand Function is reported, scores range from 0-100, with higher scores indicating a better outcome.</description>
        <time_frame>Baseline, End of Treatment (8 weeks); End of Treatment + 4 week (12 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Repetitive Task Practice (RTP)</title>
            <description>This group focuses on RTP.
Repetitive Task Practice (RTP): This group will preform arm and hand therapy.</description>
          </group>
          <group group_id="O2">
            <title>Voluntary Cycling + RTP</title>
            <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Voluntary cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
          </group>
          <group group_id="O3">
            <title>Assisted Cycling + RTP</title>
            <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Assisted cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
          </group>
        </group_list>
        <measure>
          <title>The Stroke Impact Scale (SIS)</title>
          <description>This is a self-reported questionnaire evaluating quality of life. Normalized Hand Function is reported, scores range from 0-100, with higher scores indicating a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.67" spread="35.73"/>
                    <measurement group_id="O2" value="34.38" spread="28.72"/>
                    <measurement group_id="O3" value="50.83" spread="32.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EOT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.00" spread="26.93"/>
                    <measurement group_id="O2" value="45.00" spread="41.95"/>
                    <measurement group_id="O3" value="68.33" spread="15.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EOT+4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.00" spread="22.75"/>
                    <measurement group_id="O2" value="51.67" spread="37.24"/>
                    <measurement group_id="O3" value="66.67" spread="22.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Repetitive Task Practice (RTP)</title>
          <description>This group focuses on RTP.
Repetitive Task Practice (RTP): This group will preform arm and hand therapy.</description>
        </group>
        <group group_id="E2">
          <title>Voluntary Cycling + RTP</title>
          <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Voluntary cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
        </group>
        <group group_id="E3">
          <title>Assisted Cycling + RTP</title>
          <description>This group involves one biking session and one RTP session three times per week for eight weeks.
Assisted cycling + RTP: This group will preform arm and hand therapy and cycle on a bike.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Recurrent stroke</sub_title>
                <description>One participant had a fatal recurrent stroke approximately 36 hours after the intervention. Upon reviewing the subject's medical history and stress test, the Patient Safety Monitoring Board unanimously concluded it was not due to the study.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jay Alberts</name_or_title>
      <organization>Cleveland Clinic</organization>
      <phone>216 445-3222</phone>
      <email>albertj@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

